株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

肺活量計の世界市場の分析:企業プロファイル、市場規模・シェア・成長率・傾向・将来予測

Global Spirometer Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

発行 Data Bridge Market Research Private Limited 商品コード 590842
出版日 ページ情報 英文 350 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
肺活量計の世界市場の分析:企業プロファイル、市場規模・シェア・成長率・傾向・将来予測 Global Spirometer Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
出版日: 2017年11月01日 ページ情報: 英文 350 Pages
概要

当レポートでは、世界の肺活量計 (スパイロメーター) 市場について分析し、市場の概況や市場シェア構造、主な市場促進・抑制要因、市場規模の動向見通し (今後8年間分)、製品種類別・技術別・用途別・エンドユーザー別・流通チャネル別・地域別の詳細動向、市場競争環境、主要企業のプロファイルなどを調査しております

第1章 イントロダクション

第2章 市場の内訳

第3章 市場概要

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 課題

第4章 エグゼクティブ・サマリー

第5章 重要考察

第6章 世界の肺活量計市場:製品種類別

  • 概要
  • 卓上式肺活量計
  • 携帯型 (ハンドヘルド式) 肺活量計
  • デスクトップ (PC) 肺活量計

第7章 世界の肺活量計市場:技術別

  • 概要
  • 容積測定型肺活量計 (湿式・乾式)
  • 流量測定型肺活量計 (ニューモタコグラフシステム・マスフローメーター)
  • PFM (ピークフローメーター)

第8章 世界の肺活量計市場:用途別

  • 概要
  • 診断用
  • 治療用

第9章 世界の肺活量計市場:エンドユーザー別

  • 概要
  • 病院
  • クリニック
  • 在宅治療

第10章 世界の肺活量計市場:流通チャネル別

  • 概要
  • 店舗販売型 (OTC)
  • 直接販売・納入型

第11章 世界の肺活量計市場:地域別

  • 各国市場の詳細動向 (製品種類別、技術別、用途別、エンドユーザー別、流通チャネル別)
    • 北米 (米国、カナダ、メキシコ)
    • 欧州 (ドイツ、フランス、英国、イタリア、スペイン、ロシア、トルコ、ベルギー、オランダ、スイスなど)
    • アジア太平洋地域 (日本、中国、韓国、インド、オーストラリア、シンガポール、タイ、マレーシア、インドネシア、フィリピンなど)
    • ラテンアメリカ市場 (ブラジルなど)
    • 中東・アフリカ市場 (南アフリカなど)
  • 主要国市場の詳細分析

第12章 世界の肺活量計市場:競争環境

  • 企業別市場シェアの分析:全世界
  • 企業別市場シェアの分析:北米
  • 企業別市場シェアの分析:欧州
  • 企業別市場シェアの分析:アジア太平洋地域
  • 企業別市場シェアの分析:中東・アフリカ
  • 企業別市場シェアの分析:南米
  • 企業合併・買収 (M&A)
  • 新製品の上市・認証
  • 事業拡張
  • 規制面での問題
  • 事業提携、その他の戦略展開状況

第13章 世界の肺活量計市場:企業プロファイル

  • WELCH ALLYN
    • 企業概要
    • 財務分析
    • 製品マトリックス
    • 近年の主な動き
    • DATABRIDGEの分析
  • MIDMARK CORP.
  • FUTUREMED
  • COSMED
  • MGC DIAGNOSTICS CORPORATION
  • 日本光電
  • CAREFUSION CORPORATION
  • MEDICAL INTERNATIONAL RESEARCH
  • VITALOGRAPH
  • NDD MEDICAL TECHNOLOGIES, INC.
  • SCHILLER AG
  • JONES MEDICAL INSTRUMENT COMPANY

第14章 付録

第15章 DATA BRIDGE MARKET RESEARCHについて

目次

The Global Spirometer Market is accounted to reach USD 1,041.3 million by 2024 from USD 553.9 million in 2016; it is growing at a CAGR of 8.3%.

The major factors driving the growth of this market are increasing prevalence of respiratory diseases, increased demand of homecare setting devices, and rise in the number of smokers.

The key market players for Global Spirometer Market are listed below:

BD,

Midmark Corp.

Welch allyn

SDI Diagnostics,

Geratherm Respiratory GMBH,

The market is further segmented into:

Type

Application

End User

Geography

The Global spirometer market is segmented on the basis of product type, technology, disease, disposable components, application, end-user and distribution channel. On the basis of product type, the Global spirometer market is segmented into table-top spirometer, hand-held spirometer and pc based spirometer. In 2017, table-top spirometer is expected to dominate the Global spirometer market with 39.3% market share and is expected to reach USD 404.4 million by 2024, growing a CAGR of 8.2% in the forecast period 2017 to 2024.

Based on technology, the Global spirometer market is segmented into volume measurement spirometer, flow measurement spirometer and peak flow meter. In 2017, flow measurement spirometer is expected to dominate the Global spirometer market with 67.3% market share and is expected to reach USD 719.5 million by 2024, growing at a CAGR of 8.7% in the forecast period 2017 to 2024.

Based on disease, the Global spirometer market is segmented into asthma, bronchitis, emphysema, chronic obstructive lung disease, lung cancer, and others. In 2017, chronic obstructive lung disease is expected to dominate the Global spirometer market with 40.5% market share and is expected to reach USD 438.2 million by 2024, growing with the highest CAGR of 8.9% in the forecast period 2017 to 2024.

Based on disposable components, the Global spirometer market is segmented into filters, tubes and sensors. In 2017, filters is expected to dominate the Global spirometer market with 74.0% market share and is expected to reach USD 781.6 million by 2024, growing with the highest CAGR of 8.6% in the forecast period 2017 to 2024.

Based on application, the Global spirometer market is segmented into diagnostics and therapeutic. In 2017, diagnostics is expected to dominate the Global spirometer market with 65.4% market share and is expected to reach USD 707.2 million by 2024, growing with the highest CAGR of 8.9% in the forecast period 2017 to 2024.

Based on end-user, the Global spirometer market is segmented into hospitals, clinics and homecare. In 2017, hospitals is expected to dominate the Global spirometer market with 50.0% market share and is expected to reach USD 537.0 million by 2024, growing at a CAGR of 8.8% in the forecast period 2017 to 2024.

Based on distribution channel, the Global spirometer market is segmented into direct tender and over the counter. In 2017, direct tender is expected to dominate the Global spirometer market with 64.4% market share and is expected to reach USD 684.0 million by 2024, growing at a CAGR of 8.6% in the forecast period 2017 to 2024.

Based on geography, the Global Spirometer market is segmented into 11 geographical regions, such as,

North America,

South America,

Europe,

APAC,

MEA

Covered in this report

The report covers the present scenario and the growth prospects of the Global Spirometer market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

TABLE OF CONTENTS

INTRODUCTION

  • 1.1. OVERVIEW OF THE GLOBAL SPIROMETER MARKET
  • 1.2. CURRENCY AND PRICING
  • 1.3. LIMITATION
  • 1.4. MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1. KEY TAKEAWAYS
  • 2.2. ARRIVING AT THE GLOBAL SPIROMETER MARKET SIZE
    • 2.2.1. MARKET CRACKDOWN APPROACH
    • 2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
    • 2.2.3. DATA TRIANGULATION
    • 2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
    • 2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
    • 2.2.6 PORTER'S FIVE FORCES MATRIX
    • 2.2.7 PEST ANALYSIS
    • 2.2.8. EPIDEMIOLOGY FORECASTING MODELS
  • 2.3. GLOBAL SPIROMETER MARKET: RESEARCH SNAPSHOT
  • 2.4. ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1. DRIVERS
  • 3.2. RESTRAINTS
  • 3.3. OPPORTUNITIES
  • 3.4. CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL SPIROMETER MARKET, BY PRODUCT TYPE

  • 6.1. OVERVIEW
  • 6.2. TABLE-TOP SPIROMETER
  • 6.3. HAND-HELD SPIROMETER
  • 6.4. DESKTOP(PC) SPIROMETER

7 GLOBAL SPIROMETER MARKET, BY TECHNOLOGY

  • 7.1. OVERVIEW
  • 7.2. VOLUME MEASUREMENT SPIROMETER(WET AND DRY)
  • 7.3. FLOW MEASUREMENT SPIROMETER (PNEUMOTACHOGRAPH SYSTEM AND MASS FLOW METER)
  • 7.4. PEAK FLOW METER (PFM)

8 GLOBAL SPIROMETER MARKET, BY APPLICATION

  • 8.1. OVERVIEW
  • 8.2. DIAGNOSTIC
  • 8.3. THERAPEUTIC

9 GLOBAL SPIROMETER MARKET, BY END USER

  • 9.1. OVERVIEW
  • 9.2. HOSPITALS
  • 9.3. CLINIC
  • 9.4. HOMECARE

10 GLOBAL SPIROMETER MARKET, BY APPLICATION

  • 10.1. OVERVIEW
  • 10.2. OVER THE COUNTER
  • 10.3. DIRECT TENDER

11 GLOBAL SPIROMETER MARKET, BY GEOGRAPHY

  • 11.1. COUNTRYWISE GLOBAL SPIROMETER MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
    • 11.1.1. NORTH AMERICA
      • 11.1.1.1. U.S.
      • 11.1.1.2. CANADA
      • 11.1.1.3. MEXICO
    • 11.1.2. EUROPE
      • 11.1.2.1. GERMANY
      • 11.1.2.2. FRANCE
      • 11.1.2.3. U.K.
      • 11.1.2.4 ITALY
      • 11.1.2.5 SPAIN
      • 11.1.2.6 RUSSIA
      • 11.1.2.7 TURKEY
      • 11.1.2.8 BELGIUM

11.1.2.9NETHERLANDS

      • 11.1.2.10 SWITZERLAND
      • 11.1.2.11 REST OF EUROPE
    • 11.1.3 ASIA-PACIFIC (APAC)
      • 11.1.3.1 JAPAN
      • 11.1.3.2 CHINA
      • 11.1.3.3 SOUTH KOREA
      • 11.1.3.4 INDIA
      • 11.1.3.5 AUSTRALIA
      • 11.1.3.6 SINGAPORE
      • 11.1.3.7 THAILAND
      • 11.1.3.8 MALAYSIA
      • 11.1.3.9 INDONESIA
      • 11.1.3.10 PHILIPPINES
      • 11.1.3.11 REST OF APAC
    • 11.1.4 LATIN AMERICA
      • 11.1.4.1 BRAZIL
      • 11.1.4.2 REST OF LATIN AMERICA
    • 11.1.5 MIDDLE EAST AND AFRICA
      • 11.1.5.1 SOUTH AFRICA
      • 11.1.5.2 REST OF MIDDLE EAST AND AFRICA
  • 11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

12 GLOBAL SPIROMETER MARKET: COMPETITIVE LANDSCAPE

  • 12.1. GLOBAL SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.2. NORTH AMERICA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.3. EUROPE SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.4. APAC SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.5. MEA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.6. SOUTH AMERICA SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 12.7. MERGERS & ACQUISITIONS
  • 12.8. NEW PRODUCT DEVELOPMENT & APPROVALS
  • 12.9. EXPANSIONS
  • 12.10. REGULATORY CHANGES
  • 12.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS 13 GLOBAL SPIROMETER MARKET, COMPANY PROFILES

13 GLOBAL SPIROMETER MARKET, COMPANY PROFILES

  • 13.1 WELCH ALLYN
    • 13.1.1 COMPANY OVERVIEW
    • 13.1.2 FINANCIAL ANALYSIS
    • 13.1.3 PRODUCT MATRIX
    • 13.1.4 RECENT DEVELOPMENTS
    • 13.1.5 DATABRIDGE ANALYSIS
  • 13.2 MIDMARK CORP.
    • 13.2.1 COMPANY OVERVIEW
    • 13.2.2 FINANCIAL ANALYSIS
    • 13.2.3 PRODUCT MATRIX
    • 13.2.4 RECENT DEVELOPMENTS
    • 13.2.5 DATABRIDGE ANALYSIS
  • 13.3 FUTUREMED
    • 13.3.1 COMPANY OVERVIEW
    • 13.3.2 FINANCIAL ANALYSIS
    • 13.3.3 PRODUCT MATRIX
    • 13.3.4 RECENT DEVELOPMENTS
    • 13.3.5 DATABRIDGE ANALYSIS
  • 13.4 COSMED
    • 13.4.1 COMPANY OVERVIEW
    • 13.4.2 FINANCIAL ANALYSIS
    • 13.4.4 PRODUCT MATRIX
    • 13.4.4 RECENT DEVELOPMENTS
    • 13.4.5 DATABRIDGE ANALYSIS
  • 13.5 MGC DIAGNOSTICS CORPORATION
    • 13.5.1 COMPANY OVERVIEW
    • 13.5.2 FINANCIAL ANALYSIS
    • 13.5.3 PRODUCT MATRIX
    • 13.5.4 RECENT DEVELOPMENTS
    • 13.5.5 DATABRIDGE ANALYSIS
  • 13.6 NIHON KOHDEN CORPORATION
    • 13.6.1 COMPANY OVERVIEW
    • 13.6.2 FINANCIAL ANALYSIS
    • 13.6.3 PRODUCT MATRIX
    • 13.6.4 RECENT DEVELOPMENTS
    • 13.6.5 DATABRIDGE ANALYSIS
  • 13.7 CAREFUSION CORPORATION
    • 13.7.1 COMPANY OVERVIEW
    • 13.7.2 FINANCIAL ANALYSIS
    • 13.7.3 PRODUCT MATRIX
    • 13.7.4 RECENT DEVELOPMENTS
    • 13.7.5 DATABRIDGE ANALYSIS
  • 13.8 MEDICAL INTERNATIONAL RESEARCH
    • 13.8.1 COMPANY OVERVIEW
    • 13.8.2 FINANCIAL ANALYSIS
    • 13.8.3 PRODUCT MATRIX
    • 13.8.4 RECENT DEVELOPMENTS
    • 13.8.5 DATABRIDGE ANALYSIS
  • 13.9 VITALOGRAPH
    • 13.9.1 COMPANY OVERVIEW
    • 13.9.2 FINANCIAL ANALYSIS
    • 13.9.3 PRODUCT MATRIX
    • 13.9.4 RECENT DEVELOPMENTS
    • 13.9.5 DATABRIDGE ANALYSIS
  • 13.10 NDD MEDICAL TECHNOLOGIES, INC.
    • 13.10.1 COMPANY OVERVIEW
    • 13.10.2 FINANCIAL ANALYSIS
    • 13.10.3 PRODUCT MATRIX
    • 13.10.4 RECENT DEVELOPMENTS
    • 13.10.5 DATABRIDGE ANALYSIS
  • 13.11 SCHILLER AG
    • 13.11.1 COMPANY OVERVIEW
    • 13.11.2 FINANCIAL ANALYSIS
    • 13.11.3 PRODUCT MATRIX
    • 13.11.4 RECENT DEVELOPMENTS
    • 13.11.5 DATABRIDGE ANALYSIS
  • 13.12 JONES MEDICAL INSTRUMENT COMPANY
    • 13.12.1 COMPANY OVERVIEW
    • 13.12.2 FINANCIAL ANALYSIS
    • 13.12.3 PRODUCT MATRIX
    • 13.12.4 RECENT DEVELOPMENTS
    • 13.12.5 DATABRIDGE ANALYSIS

14 APPENDIX

15 ABOUT DATA BRIDGE MARKET RESEARCH

Back to Top